{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:13:56Z","timestamp":1790633636409,"version":"4.1.0"},"reference-count":31,"publisher":"BMJ","issue":"8","funder":[{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Latvian Research Council"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2017,6,21]]},"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Population-based eradication of\n                      <jats:italic>Helicobacter pylori<\/jats:italic>\n                      has been suggested to be cost-effective and is recommended by international guidelines. However, the potential adverse effects of widespread antibiotic use that this would entail have not been sufficiently studied. An alternative way to decrease gastric cancer mortality is by non-invasive search for precancerous lesions, in particular gastric atrophy; pepsinogen tests are the best currently available alternative. The primary objective of GISTAR is to determine whether\n                      <jats:italic>H pylori<\/jats:italic>\n                      eradication combined with pepsinogen testing reduces mortality from gastric cancer among 40\u201364-year-old individuals. The secondary objectives include evaluation of\n                      <jats:italic>H pylori<\/jats:italic>\n                      eradication effectiveness in gastric cancer prevention in patients with precancerous lesions and evaluation of the potential adverse events, including effects on microbiome.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>\n                      Individuals are recruited from general population (50% men) in areas with high gastric cancer risk in Europe and undergo detailed lifestyle and medical history questionnaire before being randomly allocated to intervention or control groups. The intervention group undergoes\n                      <jats:italic>H pylori<\/jats:italic>\n                      testing and is offered eradication therapy if positive; in addition, pepsinogen levels are detected in plasma and those with decreased levels are referred for upper endoscopy. All participants are offered faecal occult blood testing as an incentive for study participation. Effectiveness of eradication and the spectrum of adverse events are evaluated in study subpopulations. A 35% difference in gastric cancer mortality between the groups is expected to be detectable at 90% power after 15 years if 30\u2009000 individuals are recruited. Biological materials are biobanked for the main and ancillary studies. The study procedure and assumptions will be tested during the pilot phase.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The study was approved by the respective ethics committees. An independent Data Safety and Monitoring Board has been established. The findings will be published in peer-reviewed journals and presented at scientific meetings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>NCT02047994<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2017-016999","type":"journal-article","created":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T20:25:24Z","timestamp":1502483124000},"page":"e016999","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":63,"title":["Multicentric randomised study of\n                    <i>Helicobacter pylori<\/i>\n                    eradication and pepsinogen testing for prevention of gastric cancer mortality: the GISTAR study"],"prefix":"10.1136","volume":"7","clinical-trial-number":[{"clinical-trial-number":"nct02047994","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0319-8855","authenticated-orcid":false,"given":"Marcis","family":"Leja","sequence":"first","affiliation":[{"name":"Institute of Clinical and Preventive Medicine & Faculty of Medicine, University of Latvia, Riga, Latvia"},{"name":"Department of Research, Riga East University Hospital, Riga, Latvia"},{"name":"Digestive Diseases Centre GASTRO, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Young","family":"Park","sequence":"additional","affiliation":[{"name":"Prevention and Implementation Group, International Agency for Research on Cancer, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Murillo","sequence":"additional","affiliation":[{"name":"Prevention and Implementation Group, International Agency for Research on Cancer, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inta","family":"Liepniece-Karele","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Preventive Medicine & Faculty of Medicine, University of Latvia, Riga, Latvia"},{"name":"Department of Research, Riga East University Hospital, Riga, Latvia"},{"name":"Academic Histology Laboratory, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergejs","family":"Isajevs","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Preventive Medicine & Faculty of Medicine, University of Latvia, Riga, Latvia"},{"name":"Department of Research, Riga East University Hospital, Riga, Latvia"},{"name":"Academic Histology Laboratory, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilze","family":"Kikuste","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Preventive Medicine & Faculty of Medicine, University of Latvia, Riga, Latvia"},{"name":"Digestive Diseases Centre GASTRO, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dace","family":"Rudzite","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Preventive Medicine & Faculty of Medicine, University of Latvia, Riga, Latvia"},{"name":"Department of Research, Riga East University Hospital, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Krike","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Preventive Medicine & Faculty of Medicine, University of Latvia, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei","family":"Parshutin","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Preventive Medicine & Faculty of Medicine, University of Latvia, Riga, Latvia"},{"name":"Institute of Information Technology, Riga Technical University, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inese","family":"Polaka","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Preventive Medicine & Faculty of Medicine, University of Latvia, Riga, Latvia"},{"name":"Institute of Information Technology, Riga Technical University, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnis","family":"Kirsners","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Preventive Medicine & Faculty of Medicine, University of Latvia, Riga, Latvia"},{"name":"Institute of Information Technology, Riga Technical University, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiga","family":"Santare","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Preventive Medicine & Faculty of Medicine, University of Latvia, Riga, Latvia"},{"name":"Department of Research, Riga East University Hospital, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valdis","family":"Folkmanis","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Preventive Medicine & Faculty of Medicine, University of Latvia, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilva","family":"Daugule","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Preventive Medicine & Faculty of Medicine, University of Latvia, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyn","family":"Plummer","sequence":"additional","affiliation":[{"name":"Infection and Cancer Epidemiology Group, International Agency for Research on Cancer, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando","family":"Herrero","sequence":"additional","affiliation":[{"name":"Prevention and Implementation Group, International Agency for Research on Cancer, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,8,11]]},"reference":[{"key":"2025121407050100000_7.8.e016999.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.10498"},{"key":"2025121407050100000_7.8.e016999.2","unstructured":"Forman D , Sierra M S . The current and projected global burden of gastric cancer. IARC Helicobacter pylori Working Group Helicobacter pylori Eradication as a Strategy for preventing gastric Cancer Lyon, France: International Agency for Research on Cancer (IARC working Group Reports, no 8):5-\u201315. http:\/\/wwwiarcfr\/en\/publications\/pdfs-online\/wrk\/wrk8\/indexphp2014."},{"key":"2025121407050100000_7.8.e016999.3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20107"},{"key":"2025121407050100000_7.8.e016999.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2009.12.014"},{"key":"2025121407050100000_7.8.e016999.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2012.12.027"},{"key":"2025121407050100000_7.8.e016999.6","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, liver flukes and Helicobacter pylori IARC Monogr Eval Carcinog risks Hum. 1994;61:1\u2013241."},{"key":"2025121407050100000_7.8.e016999.7","unstructured":"IARC. Monographs on the evaluation of carcinogenic risks to humans, volume 100. A review of carcinogen - Part B: biological agents. International Agency for Research on Cancer: Lyon, 2011."},{"key":"2025121407050100000_7.8.e016999.8","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28999"},{"key":"2025121407050100000_7.8.e016999.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2013.09.005"},{"key":"2025121407050100000_7.8.e016999.10","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12050"},{"key":"2025121407050100000_7.8.e016999.11","unstructured":"Moayyedi P . Feasibility and cost effectiveness of population-based H. pylori eradication. IARC Helicobacter pylori Working Group Helicobacter pylori Eradication as a Strategy for preventing gastric Cancer Lyon, France: International Agency for Research on Cancer (IARC working Group Reports, no 8); pp. 180:174. http:\/\/wwwiarcfr\/en\/publications\/pdfs-online\/wrk\/wrk8\/indexphp2014."},{"key":"2025121407050100000_7.8.e016999.12","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309252"},{"key":"2025121407050100000_7.8.e016999.13","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312288"},{"key":"2025121407050100000_7.8.e016999.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60235-9"},{"key":"2025121407050100000_7.8.e016999.15","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.405"},{"key":"2025121407050100000_7.8.e016999.16","unstructured":"Lonnberg S , Sekerija M , Malila N , et al . Cancer screening: policy recommendations on governance, organization and evaluation of cancer screening. European Guide on Quality Improvement in Comprehensive Cancer control. Belgium: National Institute of Public Health, Slovenia, Scientific Institute of Public Health, Belgium, 2017:39\u201376. http:\/\/wwwcancercontroleu\/guide-landing-page\/"},{"key":"2025121407050100000_7.8.e016999.17","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.bpg.2014.09.008","article-title":"The global challenge of a healthy stomach","volume":"28","author":"Bornschein","year":"2014","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2025121407050100000_7.8.e016999.18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142080","article-title":"Significance of serum pepsinogens as a biomarker for gastric Cancer and atrophic gastritis screening: a systematic review and Meta-Analysis","volume":"10","author":"Huang","year":"2015","journal-title":"PLoS One"},{"key":"2025121407050100000_7.8.e016999.19","unstructured":"IARC. World Health Organization Cancer mortality database. 2015 http:\/\/www-dep.iarc.fr\/WHOdb\/WHOdb.htm (accessed 29 Feb 2016)."},{"key":"2025121407050100000_7.8.e016999.20","doi-asserted-by":"crossref","first-page":"e12393","DOI":"10.1111\/hel.12393","article-title":"Detection of gastric atrophy by circulating pepsinogens: A comparison of three assays","volume":"22","author":"Leja","year":"2017","journal-title":"Helicobacter"},{"key":"2025121407050100000_7.8.e016999.21","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199610000-00001"},{"key":"2025121407050100000_7.8.e016999.22","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000357862","article-title":"Management of Helicobacter pylori-related diseases in the Baltic States","volume":"32","author":"Kupcinskas","year":"2014","journal-title":"Dig Dis"},{"key":"2025121407050100000_7.8.e016999.23","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1291491"},{"key":"2025121407050100000_7.8.e016999.24","unstructured":"Ferlay J , Shin HR , Bray F , et al . GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer, 2010. http:\/\/globocaniarcfr. (accessed 22 Dec 2011)."},{"key":"2025121407050100000_7.8.e016999.25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g3174"},{"key":"2025121407050100000_7.8.e016999.26","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e3283583ca5"},{"key":"2025121407050100000_7.8.e016999.27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3109\/00365521.2011.645501","article-title":"Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers","volume":"47","author":"Agr\u00e9us","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"2025121407050100000_7.8.e016999.28","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwj088"},{"key":"2025121407050100000_7.8.e016999.29","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-07-2762"},{"key":"2025121407050100000_7.8.e016999.30","first-page":"247","article-title":"Stomach-specific biomarkers (GastroPanel) Can predict the development of gastric Cancer in a caucasian Population: a Longitudinal Nested Case-Control Study in Siberia","volume":"36","author":"Kurilovich","year":"2016","journal-title":"Anticancer Res"},{"key":"2025121407050100000_7.8.e016999.31","doi-asserted-by":"publisher","DOI":"10.2183\/pjab.87.405"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2017-016999","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T15:05:08Z","timestamp":1765724708000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2017-016999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8,11]]},"published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.1136\/bmjopen-2017-016999"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2017-016999","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}